Skip to content

Blog

Paolo Rossi Castelli10 Feb 20222 min read

Magnesium helps immunotherapy for tumours

Encouraging results of a study from Basel. Magnesium activates a protein on the outer wall of T lymphocytes, essential for boosting defences.
Start Reading
Paolo Rossi Castelli03 Feb 20223 min read

A marker to measure depression

A blood test can determine the activity of a key molecule in depressive disorders and the effect of treatment, without having to wait weeks or months.
Start Reading
Giacinto Di Pietrantonio01 Feb 20225 min read

Infinite development

Digital art increasingly blurs the fine line between artist and observer. Chromata, one of Michael Bromley’s interactive works, is an example.
Start Reading
Paolo Rossi Castelli27 Jan 20222 min read

More ‘tailored’ vaccines for dog allergies

Japanese researchers have managed to pinpoint spots on certain molecules produced by dogs that are the strongest allergens. Possible new vaccines.
Start Reading
Paolo Rossi Castelli20 Jan 20223 min read

Type 1 diabetes: new stem cell treatments

Positive results for a technique tested on 26 patients by a team of international researchers. The cells differentiate in six months and produce insulin.
Start Reading
Catterina Seia18 Jan 20226 min read

Hidden Resources

Call for Case Studies – operators and experts of Culture and Health submited projects that are currently being developed and implemented in Switzerland
Start Reading
Paolo Rossi Castelli13 Jan 20222 min read

A cure for astronauts’ eyes

Successfully tested a sleeping bag that returns fluids to the feet in absence of gravity, preventing them from accumulating in the skull and damaging eyes.
Start Reading
Paolo Rossi Castelli05 Jan 20223 min read

A molecule that illuminates ovarian cancer

US health authorities have given the ok to Pafolacianine, a drug that binds to a protein found in ovarian cancer cells and allows surgeons to identify them
Start Reading
Paolo Rossi Castelli29 Dec 20212 min read

A new pain-relief strategy from Arizona

A molecule (currently known as 194) has been identified that seems to be as powerful as opiates, but without the negative effects ( non-addictive).
Start Reading
Paolo Rossi Castelli22 Dec 20217 min read

The Alliance for a sustainable future involves Art, Music and Architecture.

Primo Forum svizzero “Cultura e Salute – Alleanza per un futuro sostenibile”: due giornate di confronto sull’umanizzazione della cura e dei suoi spazi.
Start Reading
Paolo Rossi Castelli16 Dec 20212 min read

Two new strategies to fight Alzheimer’s disease

Two new trials to fight Alzheimer have produced successful results. These are a vaccine and a soluble form of beta amyloid protein typical of Alzheimer’s.
Start Reading
Paolo Rossi Castelli13 Dec 20212 min read

New molecules regenerate nerve fibres

Breakthrough results have been achieved in the USA. It is still early days for using on spinal injuries, but it seems to offer promising research potential
Start Reading
Catterina Seia08 Dec 20216 min read

Creative Ageing. Adding days to life and life to days

The role of culture in active ageing. Best practices from the Netherlands.
Start Reading
Paolo Rossi Castelli02 Dec 20212 min read

ALS, a new technique to block the wrong DNA

A therapy that can prevent DNA from copying genetic traits that may lead to hereditary forms of ALS has been successfully tested (so far only in the lab).
Start Reading
Paolo Rossi Castelli25 Nov 20213 min read

Is sleep really only good for the brain?

New studies reveal that even living beings with no nervous system need to sleep. Other parts of the body are affected like immune and digestive systems.
Start Reading
Paolo Rossi Castelli18 Nov 20212 min read

A 'liquid' vest to measure breath

Researchers have created a high-tech fabric that can detect slightest vibration. It will be useful for athletes, singers, and patients in rehabilitation.
Start Reading
Paolo Rossi Castelli11 Nov 20213 min read

‘Friendly’ viruses to defeat the most dangerous bacteria

A recent study has reproposed the idea of using ‘phages’- viruses that are harmless to humans but often lethal for bacteria – instead of antibiotics.
Start Reading
Paolo Rossi Castelli04 Nov 20214 min read

A vaccine ingredient (in short supply) from Chile

The bark of the Quillaja Saponaria tree contains saponins used as ‘adjuvants’ in the Covid vaccines by Novavax. However, excess demand may cause problems.
Start Reading